Canada markets close in 23 minutes

Sutro Biopharma, Inc. (S09.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
6.50-0.15 (-2.26%)
As of 09:15AM CET. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) 383.61M
Enterprise Value 137.25M
Trailing P/E 82.31
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)4.96
Price/Book (mrq)1.80
Enterprise Value/Revenue 1.97
Enterprise Value/EBITDA -1.25

Trading Information

Stock Price History

Beta (5Y Monthly) 0.93
52-Week Change 3-20.83%
S&P500 52-Week Change 3-7.75%
52 Week High 38.65
52 Week Low 33.20
50-Day Moving Average 36.93
200-Day Moving Average 35.90

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 557.48M
Implied Shares Outstanding 6N/A
Float 848.44M
% Held by Insiders 15.66%
% Held by Institutions 189.60%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2021
Most Recent Quarter (mrq)Sept 30, 2022

Profitability

Profit Margin -175.85%
Operating Margin (ttm)-164.27%

Management Effectiveness

Return on Assets (ttm)-18.56%
Return on Equity (ttm)-47.82%

Income Statement

Revenue (ttm)69.79M
Revenue Per Share (ttm)1.45
Quarterly Revenue Growth (yoy)195.30%
Gross Profit (ttm)-42.52M
EBITDA -109.17M
Net Income Avi to Common (ttm)-122.73M
Diluted EPS (ttm)-2.35
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)324.25M
Total Cash Per Share (mrq)5.64
Total Debt (mrq)52.95M
Total Debt/Equity (mrq)23.05
Current Ratio (mrq)5.95
Book Value Per Share (mrq)4.20

Cash Flow Statement

Operating Cash Flow (ttm)5.83M
Levered Free Cash Flow (ttm)-33.79M